The regulatory landscape of the human HPF1-and ARH3-dependent ADP-ribosylome

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The regulatory landscape of the human HPF1-and ARH3-dependent ADP-ribosylome. / Hendriks, Ivo A.; Buch-Larsen, Sara C.; Prokhorova, Evgeniia; Elsborg, Jonas D.; Rebak, Alexandra K. L. F. S.; Zhu, Kang; Ahel, Dragana; Lukas, Claudia; Ahel, Ivan; Nielsen, Michael L.

In: Nature Communications, Vol. 12, No. 1, 5893, 2021.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hendriks, IA, Buch-Larsen, SC, Prokhorova, E, Elsborg, JD, Rebak, AKLFS, Zhu, K, Ahel, D, Lukas, C, Ahel, I & Nielsen, ML 2021, 'The regulatory landscape of the human HPF1-and ARH3-dependent ADP-ribosylome', Nature Communications, vol. 12, no. 1, 5893. https://doi.org/10.1038/s41467-021-26172-4

APA

Hendriks, I. A., Buch-Larsen, S. C., Prokhorova, E., Elsborg, J. D., Rebak, A. K. L. F. S., Zhu, K., Ahel, D., Lukas, C., Ahel, I., & Nielsen, M. L. (2021). The regulatory landscape of the human HPF1-and ARH3-dependent ADP-ribosylome. Nature Communications, 12(1), [5893]. https://doi.org/10.1038/s41467-021-26172-4

Vancouver

Hendriks IA, Buch-Larsen SC, Prokhorova E, Elsborg JD, Rebak AKLFS, Zhu K et al. The regulatory landscape of the human HPF1-and ARH3-dependent ADP-ribosylome. Nature Communications. 2021;12(1). 5893. https://doi.org/10.1038/s41467-021-26172-4

Author

Hendriks, Ivo A. ; Buch-Larsen, Sara C. ; Prokhorova, Evgeniia ; Elsborg, Jonas D. ; Rebak, Alexandra K. L. F. S. ; Zhu, Kang ; Ahel, Dragana ; Lukas, Claudia ; Ahel, Ivan ; Nielsen, Michael L. / The regulatory landscape of the human HPF1-and ARH3-dependent ADP-ribosylome. In: Nature Communications. 2021 ; Vol. 12, No. 1.

Bibtex

@article{d3f00513da19496b8859597113e43a33,
title = "The regulatory landscape of the human HPF1-and ARH3-dependent ADP-ribosylome",
abstract = "ADP-ribosylation is regulated by HPF1 and ARH3, but the cellular target spectrum of these enzymes is not fully understood. Here, the authors use quantitative proteomics to define the HPF1- and ARH3-dependent ADP-ribosylome, providing evidence that mono-ADP-ribosylation of serine predominates in cells.Despite the involvement of Poly(ADP-ribose) polymerase-1 (PARP1) in many important biological pathways, the target residues of PARP1-mediated ADP-ribosylation remain ambiguous. To explicate the ADP-ribosylation regulome, we analyze human cells depleted for key regulators of PARP1 activity, histone PARylation factor 1 (HPF1) and ADP-ribosylhydrolase 3 (ARH3). Using quantitative proteomics, we characterize 1,596 ADP-ribosylation sites, displaying up to 1000-fold regulation across the investigated knockout cells. We find that HPF1 and ARH3 inversely and homogenously regulate the serine ADP-ribosylome on a proteome-wide scale with consistent adherence to lysine-serine-motifs, suggesting that targeting is independent of HPF1 and ARH3. Notably, we do not detect an HPF1-dependent target residue switch from serine to glutamate/aspartate under the investigated conditions. Our data support the notion that serine ADP-ribosylation mainly exists as mono-ADP-ribosylation in cells, and reveal a remarkable degree of histone co-modification with serine ADP-ribosylation and other post-translational modifications.",
keywords = "ACETYLATION POSTTRANSLATIONAL MODIFICATIONS, POLY(ADENOSINE DIPHOSPHATE RIBOSYLATION), DNA-DAMAGE RESPONSE, POLY(ADP-RIBOSE) POLYMERASE, IDENTIFICATION, SERINE, CHROMATIN, PROTEOME, STRATEGY, HISTONES",
author = "Hendriks, {Ivo A.} and Buch-Larsen, {Sara C.} and Evgeniia Prokhorova and Elsborg, {Jonas D.} and Rebak, {Alexandra K. L. F. S.} and Kang Zhu and Dragana Ahel and Claudia Lukas and Ivan Ahel and Nielsen, {Michael L.}",
year = "2021",
doi = "10.1038/s41467-021-26172-4",
language = "English",
volume = "12",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "nature publishing group",
number = "1",

}

RIS

TY - JOUR

T1 - The regulatory landscape of the human HPF1-and ARH3-dependent ADP-ribosylome

AU - Hendriks, Ivo A.

AU - Buch-Larsen, Sara C.

AU - Prokhorova, Evgeniia

AU - Elsborg, Jonas D.

AU - Rebak, Alexandra K. L. F. S.

AU - Zhu, Kang

AU - Ahel, Dragana

AU - Lukas, Claudia

AU - Ahel, Ivan

AU - Nielsen, Michael L.

PY - 2021

Y1 - 2021

N2 - ADP-ribosylation is regulated by HPF1 and ARH3, but the cellular target spectrum of these enzymes is not fully understood. Here, the authors use quantitative proteomics to define the HPF1- and ARH3-dependent ADP-ribosylome, providing evidence that mono-ADP-ribosylation of serine predominates in cells.Despite the involvement of Poly(ADP-ribose) polymerase-1 (PARP1) in many important biological pathways, the target residues of PARP1-mediated ADP-ribosylation remain ambiguous. To explicate the ADP-ribosylation regulome, we analyze human cells depleted for key regulators of PARP1 activity, histone PARylation factor 1 (HPF1) and ADP-ribosylhydrolase 3 (ARH3). Using quantitative proteomics, we characterize 1,596 ADP-ribosylation sites, displaying up to 1000-fold regulation across the investigated knockout cells. We find that HPF1 and ARH3 inversely and homogenously regulate the serine ADP-ribosylome on a proteome-wide scale with consistent adherence to lysine-serine-motifs, suggesting that targeting is independent of HPF1 and ARH3. Notably, we do not detect an HPF1-dependent target residue switch from serine to glutamate/aspartate under the investigated conditions. Our data support the notion that serine ADP-ribosylation mainly exists as mono-ADP-ribosylation in cells, and reveal a remarkable degree of histone co-modification with serine ADP-ribosylation and other post-translational modifications.

AB - ADP-ribosylation is regulated by HPF1 and ARH3, but the cellular target spectrum of these enzymes is not fully understood. Here, the authors use quantitative proteomics to define the HPF1- and ARH3-dependent ADP-ribosylome, providing evidence that mono-ADP-ribosylation of serine predominates in cells.Despite the involvement of Poly(ADP-ribose) polymerase-1 (PARP1) in many important biological pathways, the target residues of PARP1-mediated ADP-ribosylation remain ambiguous. To explicate the ADP-ribosylation regulome, we analyze human cells depleted for key regulators of PARP1 activity, histone PARylation factor 1 (HPF1) and ADP-ribosylhydrolase 3 (ARH3). Using quantitative proteomics, we characterize 1,596 ADP-ribosylation sites, displaying up to 1000-fold regulation across the investigated knockout cells. We find that HPF1 and ARH3 inversely and homogenously regulate the serine ADP-ribosylome on a proteome-wide scale with consistent adherence to lysine-serine-motifs, suggesting that targeting is independent of HPF1 and ARH3. Notably, we do not detect an HPF1-dependent target residue switch from serine to glutamate/aspartate under the investigated conditions. Our data support the notion that serine ADP-ribosylation mainly exists as mono-ADP-ribosylation in cells, and reveal a remarkable degree of histone co-modification with serine ADP-ribosylation and other post-translational modifications.

KW - ACETYLATION POSTTRANSLATIONAL MODIFICATIONS

KW - POLY(ADENOSINE DIPHOSPHATE RIBOSYLATION)

KW - DNA-DAMAGE RESPONSE

KW - POLY(ADP-RIBOSE) POLYMERASE

KW - IDENTIFICATION

KW - SERINE

KW - CHROMATIN

KW - PROTEOME

KW - STRATEGY

KW - HISTONES

U2 - 10.1038/s41467-021-26172-4

DO - 10.1038/s41467-021-26172-4

M3 - Journal article

C2 - 34625544

VL - 12

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 5893

ER -

ID: 282188067